CORD-19:775b90287b44353bee979abb0970a4666022f86d / 553255-553330 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Patients usually face several relapses despite discontinuation of the drug.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T66186","span":{"begin":0,"end":75},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T66186","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T4","span":{"begin":0,"end":75},"obj":"Sentence"}],"attributes":[{"subj":"T4","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1086","span":{"begin":17,"end":21},"obj":"Body_part"}],"attributes":[{"id":"A1086","pred":"uberon_id","subj":"T1086","obj":"http://purl.obolibrary.org/obo/UBERON_0001456"},{"subj":"T1086","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecb1","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec9793"},{"id":"CORD-19-PD-UBERON","color":"#93a9ec"}]}]}}